Update Knowledge Assessment and Influencing Predictor of Female Fertility Preservation in Oncologists

Abstract

Objective

This study aims to offer an update assessment of the knowledge of Chinese oncologists on female fertility preservation, and identify the determinants that influence the implementation of fertility preservation.

Methods

A total of 713 Chinese oncologists with different specialties completed the online self-report questionnaire to assess their understanding of fertility risks in cancer treatment, knowledge on female fertility preservation, and perceptions on the barriers in referring patients for fertility preservation.

Results

Although most oncologists were familiar with fertility risk in cancer treatment, half of them lacked the knowledge for reproduction and preservation methods. In the multivariable model, oncologists in a hospital with a specialized reproductive institution, positive precaution for fertility risk, and fertility preservation discussion with patients were significantly correlated with the possibility of fertility preservation referral.

Conclusions

The intervention targets based on the update evaluation and identified influencing determinants will be helpful for all the oncofertility researchers, oncologists and institutions in future efforts for well-established female fertility preservation services.

Keywords

fertility preservation / oncologists / female / infertility / neoplasms

References

[1] ChenW, ZhengR, BaadePD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132

[2] CommitteeIP, KimSS, DonnezJ, et al.. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet, 2012, 29(6): 465-468

[3] LetourneauJM, MeliskoME, CedarsMI, et al.. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol, 2011, 8(1): 56-60

[4] BaysalO, BastingsL, BeerendonkCC, et al.. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive. Hum Reprod, 2015, 30(7): 1625-1634

[5] DanilukJC, KoertE. Childless women’s beliefs and knowledge about oocyte freezing for social and medical reasons. Hum Reprod, 2016, 31(10): 2313-2320

[6] NurmioM, Asadi-AzarbaijaniB, HouM, et al.. Effect of Previous Alkylating Agent Exposure on Follicle Numbers in Cryopreserved Prepubertal and Young Adult Ovarian Tissue after Long-Term Xenografting. Cancers, 2022, 14(2): 399

[7] TozawaA, KimuraF, TakaiY, et al.. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2. Int J Clin Onco, 2022, 27(2): 281-300

[8] HargreaveM, JensenA, HansenMK, et al.. Association Between Fertility Treatment and Cancer Risk in Children. JAMA, 2019, 322(22): 2203-2210

[9] CrawshawMA, SloperP. ‘Swimming against the tide’—the influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. Eur J Cancer Care (Engl), 2010, 19(5): 610-620

[10] CarpentierMY, FortenberryJD. Romantic and sexual relationships, body image, and fertility in adolescent and young adult testicular cancer survivors: a review of the literature. J Adolesc Health, 2010, 47(2): 115-125

[11] YeeS. Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients. J Assist Reprod Genet, 2016, 33(2): 265-280

[12] KimJ, MersereauJE. Early referral makes the decision-making about fertility preservation easier: a pilot survey study of young female cancer survivors. Support Care Cancer, 2015, 23(6): 1663-1667

[13] RuddyKJ, GelberSI, TamimiRM, et al.. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol, 2014, 32(11): 1151-1156

[14] LambertiniM, HoricksF, Del MastroL, et al.. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev, 2019, 72: 65-77

[15] AdamsE, HillE, WatsonE. Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes. Br J Cancer, 2013, 108(8): 1602-1615

[16] SchoverLR, BreyK, LichtinA, et al.. Oncologists’ attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol, 2002, 20(7): 1890-1897

[17] FormanEJ, AndersCK, BeheraMA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril, 2010, 94(5): 1652-1656

[18] KloskyJL, WangF, RussellKM, et al.. Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes. J Clin Oncol, 2017, 35(34): 3830-3836

[19] YeeS, AbrolK, McDonaldM, et al.. Addressing oncofertility needs: views of female cancer patients in fertility preservation. J Psychosoc Oncol, 2012, 30(3): 331-346

[20] YeeS, Fuller-ThomsonE, LauA, et al.. Fertility preservation practices among Ontario oncologists. J Cancer Educ, 2012, 27(2): 362-368

[21] YumuraY, TsujimuraA, OkadaH, et al.. Recognition and attitudes of Japanese hematologists on sperm banking before chemotherapy: present status from nationwide questionnaire survey. Int J Clin Oncol, 2019, 24(1): 94-102

[22] KucukM, YavasogluI, BolamanAZ, et al.. Knowledge, attitudes, and practices of hematologists regarding fertility preservation in Turkey. Turk J Haematol, 2013, 30(3): 269-274

[23] Volodarsky-PerelA, CohenY, ArabS, et al.. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response. Hum Reprod, 2019, 34(3): 530-538

[24] DonnezJ, DolmansMM. Fertility Preservation in Women. N Engl J Med, 2018, 378(4): 400-401

[25] FortinA, AzaisH, UzanC, et al.. Laparoscopic ovarian tissue harvesting and orthotopic ovarian cortex grafting for fertility preservation: less is more. Fertil Steril, 2019, 111(2): 408-410

[26] SaitoK, SuzukiK, IwasakiA, et al.. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer, 2005, 104(3): 521-524

[27] AchilleMA, RosbergerZ, RobitailleR, et al.. Facilitators and obstacles to sperm banking in young men receiving gonadotoxic chemotherapy for cancer: the perspective of survivors and health care professionals. Hum Reprod, 2006, 21(12): 3206-3216

[28] SchoverLR, BreyK, LichtinA, et al.. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol, 2002, 20(7): 1880-1889

[29] GinsbergJP, OgleSK, TuchmanLK, et al.. Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives. Pediatr Blood Cancer, 2008, 50(3): 594-598

[30] PartonC, UssherJM, PerzJ. Hope, burden or risk: a discourse analytic study of the construction and experience of fertility preservation in the context of cancer. Psychol Health, 2019, 34(4): 456-477

[31] ChappleA, SalinasM, ZieblandS, et al.. Fertility issues: the perceptions and experiences of young men recently diagnosed and treated for cancer. J Adolesc Health, 2007, 40(1): 69-75

[32] MagelssenH, HaugenTB, von DuringV, et al.. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?. Eur Urol, 2005, 48(5): 779-785

[33] GirasoleCR, CooksonMS, SmithJA, et al.. Sperm banking: use and outcomes in patients treated for testicular cancer. BJU Int, 2007, 99(1): 33-36

[34] Wang M, Zhu L, Xiong H, et al. Lack of Knowledge, the main Stumbling Block of Fertility Preservation Promotion in China. J Cancer Educ, 2020. doi: https://doi.org/10.1007/s13187-020-01875-2

[35] Ben-AharonI, AbirR, PerlG, et al.. Optimizing the process of fertility preservation in pediatric female cancer patients—a multidisciplinary program. BMC Cancer, 2016, 16: 620

[36] KohlerTS, KondapalliLA, ShahA, et al.. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet, 2011, 28(3): 269-277

[37] LetourneauJM, EbbelEE, KatzPP, et al.. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer, 2012, 118(6): 1710-1717